This contract award, valued at $2,000,000.00, was made by the National Cancer Institute (NCI) to Mednet, Inc. for the 2024 SBIR TOPIC 465 program focused on "CANCER PREVENTION AND TREATMENT CLINICAL TRIALS TOOLS FOR RECRUITMENT AND RETENTION OF DIVERSE POPULATIONS". The contract is a Definitive Contract with a Firm Fixed Price pricing type and has a set-aside designation for Total Small Business. The work will be performed in New York, NY 10010 and is scheduled for completion by September 15, 2026. This award is part of the NCI's broader "ARTIFICIAL INTELLIGENCE-BASED TARGETING PLATFORM FOR RECRUITING DIVERSE CANCER" program, which aims to develop tools to improve recruitment and retention of diverse populations in cancer clinical trials.
Generated 9/28/24, 10:03 AM